Retatrutide (LY3437943) is an investigational synthetic research peptide supplied as a 20 mg lyophilised solid for laboratory investigation into GIP, GLP-1 and glucagon receptor signalling and related metabolic pathways.
Product Information
Retatrutide (LY3437943) is an investigational synthetic peptide supplied as a 20 mg lyophilised solid for laboratory research and analytical use.
Product: Retatrutide RE20-0502
Research designation: LY3437943
Strength: 20 mg per vial
Form: Lyophilised solid
Current supplier batch: RE20-0502Supplier testing: Reported purity 99.823%Reported content of tested sample: 24.70 mgAnalysis date: 21 May 2026Test reference: #156968Documentation: Supplier-provided laboratory testing report available
Intended use: Laboratory research and analytical purposes only
FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION.
Important Information
Important Information
Important Information
This product is supplied strictly for laboratory research and analytical purposes only. Not for human consumption, veterinary use, therapeutic use, cosmetic use, diagnostic use, or self-administration.By purchasing this product, the customer confirms that it will be handled only by suitably qualified individuals in an appropriate research environment and in accordance with all applicable laws and regulations.
Abyss Biotech
Retatrutide 20 mg
Retatrutide 20 mg
Couldn't load pickup availability
Share
